MACKENZIE THOMAS: Open Payments
NPI 1730855735 · HERMITAGE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,359 in 160 payments from 22 companies in 2025. Trend: 2023 $1,807 · 2024 $2,484 · 2025 $4,359
Food & beverage: $3,355Consulting: $915Education: $89
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $1,345 |
| ABBVIE INC. | 35 | $787 |
| Aimmune Therapeutics, Inc. | 17 | $356 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 21 | $320 |
| PFIZER INC. | 9 | $209 |
| Madrigal Pharmaceuticals | 5 | $197 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $151 |
| Regeneron Healthcare Solutions, Inc. | 6 | $142 |
| QOL Medical, LLC | 8 | $141 |
| Celltrion USA Inc. | 5 | $103 |
Products named: TREMFYA, ZENPEP, XIFAXAN, RINVOQ, DUPIXENT, CREON, SKYRIZI, REZDIFFRA.
Industry payments across TN — which companies pay providers there.
